Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2003
04/03/2003US20030065370 Ambulatory medical apparatus with hand held communication device
04/03/2003US20030065309 Method of delivering liquid through cerebral spinal pathway
04/03/2003US20030065308 Ambulatory medical apparatus with hand held communication device
04/03/2003US20030065040 Hypotensive agents
04/03/2003US20030065024 Mixture of tocopherol and solvent; stabilization with surfactant
04/03/2003US20030065022 Mixture of paclitaxel and surfactant; anticancer agents
04/03/2003US20030065002 Analgesics; side effect reduction
04/03/2003US20030064998 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
04/03/2003US20030064966 Bone disorders; osteoporosis
04/03/2003US20030064965 Method of delivering drugs to a tissue using drug-coated medical devices
04/03/2003US20030064961 Anaesthetic composition
04/03/2003US20030064959 Mixture with polyacrylic acid and xanthan gumo
04/03/2003US20030064958 Pharmaceutical compositions and methods relating to fucans
04/03/2003US20030064957 Reduced toxicity; enhance efficiency; side effect reduction
04/03/2003US20030064956 Myeloglycan
04/03/2003US20030064948 Invasomes for therapy of disorders, their preparation and use
04/03/2003US20030064944 Controlling cell differentiation, cell proliferation
04/03/2003US20030064943 High affinity TGFbeta nucleic acid ligands and inhibitors
04/03/2003US20030064941 Avermectin and praziquantel combination therapy
04/03/2003US20030064934 Concurrent administering of druh and hypotonic sugar solution
04/03/2003US20030064933 Transdermal administration of ACE inhibitors
04/03/2003US20030064928 Therapeutic preparations for inhalation
04/03/2003US20030064924 Complexing a water insoluble compound; forming water soluble complex; bioavailability
04/03/2003US20030064410 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids
04/03/2003US20030064133 Reducing particle size of lipophilic compound in presence of surface active agent; mixing with alkali metal alignate, adding to solution containing calcium to form beadlets; removing; rinsing with acidic solution; drying; coating
04/03/2003US20030064122 Pharmaceutical compound, and an amount of a capsaicin compound to deter intranasal, oral, and intravenous abuse while having little or no irritating effect when administered orally or transdermally as directed
04/03/2003US20030064120 Method for relaxing human beings using personal care compositions
04/03/2003US20030064119 Methods and compositions for applying essential oils and naturally occurring compounds to plants to activate endogenous plant pathogen defense pathways
04/03/2003US20030064117 For oral administration, injection and topical application
04/03/2003US20030064115 Applying voltage across cathode and anode to generate nitric oxide; contacting transport gas with solution of nitric dioxide oxide precursor to form a therapeutic gas; transporting therapeutic gas to mammal
04/03/2003US20030064108 Taste masked pharmaceutical compositions
04/03/2003US20030064107 Taste masked pharmaceutical liquid formulations
04/03/2003US20030064106 For use in cosmetics, pharmacy and food additives
04/03/2003US20030064105 Lipophilic-coated microparticle containing a protein drug and formulation comprising same
04/03/2003US20030064101 Allows immediate delivery of active agent present in an external core which in turn causes the system to float and facilitates the delivery of the drug in second osmotic core continuously in controlled manner
04/03/2003US20030064100 Metronidazole antibiotic product, use and formulation thereof
04/03/2003US20030064099 Pharmaceutical formulation containing bittering agent
04/03/2003US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
04/03/2003US20030064097 For delivery of drugs, nutrionals, cosmeceuticals and diagnostic agents
04/03/2003US20030064096 Flavored gelatin capsule and method of manufacture
04/03/2003US20030064095 Microfabricated nanopore device for sustained release of therapeutic agent
04/03/2003US20030064094 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (COPD)
04/03/2003US20030064093 For therapeutic and cosmetic application
04/03/2003US20030064092 Pharmaceutical composition containing two active ingredients for smoking cessation
04/03/2003US20030064088 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion
04/03/2003US20030064074 Recombinant gelatins in vaccines
04/03/2003US20030064052 Useful for maintaining controlled and reliable dosage of the therapeutic agent via pulmonary delivery
04/03/2003US20030064036 Coating and binding agent for pharmaceutical formulations with improved storage stability
04/03/2003US20030064034 Use of compounds in a dry powder inhaler
04/03/2003US20030064033 Propellant-based microparticle formulations
04/03/2003US20030064032 Process for nebulizing aqueous compositions containing highly concentrated insulin
04/03/2003US20030064031 For therapy of respiratory diseases such as asthma or chronic obstructive pulmonary disease
04/03/2003US20030064029 Use of a bioactive agent in manufacture of a medicament for pulmonary delivery whereby medicament comprises perforated microstructures which are aerosolized using an inhalation device to provide aerosolized medicament
04/03/2003US20030064028 Drug delivery; for inhalation therapy for pulmonary hypertension
04/03/2003US20030062646 Method for producing moulded bodies
04/03/2003US20030062043 Method and apparatus for nitric oxide generation
04/03/2003US20030062042 Aerosol generating method and device
04/03/2003CA2778208A1 Delivery system for biological component
04/03/2003CA2688860A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/03/2003CA2500453A1 Microneedle with membrane
04/03/2003CA2481020A1 Localized non-invasive biological modulation system
04/03/2003CA2464436A1 Method and topical formulation for treating skin conditions associated with aging
04/03/2003CA2461903A1 Monobactam antibacterial compounds and methods of use thereof
04/03/2003CA2461870A1 Modified release dosage forms
04/03/2003CA2461865A1 Dosage form containing a confectionery composition
04/03/2003CA2461702A1 Methods and apparatus for extrusion of vesicles at high pressure
04/03/2003CA2461693A1 Dosage form for treatment of diabetes mellitus
04/03/2003CA2461684A1 Modified release dosage forms
04/03/2003CA2461682A1 Composite dosage forms
04/03/2003CA2461656A1 Modified release dosage forms
04/03/2003CA2461653A1 Edible composition and dosage form comprising an edible shell
04/03/2003CA2461630A1 Organoleptically acceptable intraorally disintegrating compositions
04/03/2003CA2461616A1 Composite dosage forms having an inlaid portion
04/03/2003CA2461421A1 Material consisting of at least a biodegradable polymer and cyclodextrins
04/03/2003CA2461089A1 Pharmaceutically acceptable salts of 20(s)-camptothecins
04/03/2003CA2461044A1 Intraorally disintegrating valdecoxib compositions
04/03/2003CA2461042A1 Process for the preparation of fast dissolving dosage form
04/03/2003CA2460787A1 Prevention and treatment of restenosis by local administration of drug
04/03/2003CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
04/03/2003CA2459976A1 Opioid formulations having reduced potential for abuse
04/03/2003CA2447984A1 Dosage forms having an inner core and outer shell with different shapes
04/03/2003CA2446904A1 Delivery of drug esters through an inhalation route
04/03/2003CA2446760A1 Dosage forms having an inner core and outer shell
04/03/2003CA2446759A1 Modified release dosage forms
04/03/2003CA2424770A1 Solid pharmaceutical preparation
04/02/2003EP1297843A1 Method of photoreduction of hemoglobin vesicles
04/02/2003EP1297842A1 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
04/02/2003EP1297838A1 Pralmorelin-containing nasal drop preparations
04/02/2003EP1297836A1 COMPOSITIONS CONTROLLING RELEASE pH RANGE AND/OR SPEED
04/02/2003EP1297828A1 Oral formulations for localized colonic release and the method of preparation thereof
04/02/2003EP1297827A2 Film forming composition comprising sucralose and carrageenan
04/02/2003EP1297826A1 Nasal pharmaceutical compositions containing a NK-2 antagonist
04/02/2003EP1297825A1 Simethicone solid oral dosage form
04/02/2003EP1297751A1 Composition to be administered orally
04/02/2003EP1296917A2 Method for obtaining a purified hydrofluoroalkane, purified hydrofluoroalkane, use of same and method for analysing same
04/02/2003EP1296724A1 Bioadhesive composition and methods of preparation and use
04/02/2003EP1296723A1 A medicinal aerosol formulation
04/02/2003EP1296709A1 Solubilised protein vaccines
04/02/2003EP1296693A1 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor.
04/02/2003EP1296691A2 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
1 ... 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 ... 2991